JAMA Network Open

Racial and Ethnic Disparities in Medication Adherence Among Medicare Advantage Enrollees With Diabetes

By Utibe R. Essien, Eric T. Roberts, Dominic A. Ruggiero, Renuka Tipirneni

Cohort study of 587,716 peoplePopulations

The paper

Utibe R. Essien, Eric T. Roberts, Dominic A. Ruggiero, Renuka Tipirneni

University of California, Los Angeles; University of Michigan

JAMA Network Open, 1 Sep 2026

doi.org/10.1001/jamanetworkopen.2026.34846 PubMed 42804695

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19